The digital health sector increasingly relies on open physiological data. However, such data are heterogeneous: they come from different sensors, with different clinical labels, variable sampling rates and diverse capture environments. This information richness is an opportunity, but also a challenge, because it is not enough to store it: it must be turned into useful detection rules for a specific contactless monitoring platform. Artificial intelligence, and in particular large language models, offers a way to accelerate that process, provided the result is auditable and prepared for rigorous validation.
When a company wants to create a monitoring platform with non-invasive sensors, it needs to know which physiological patterns to detect: heart rate, sleep quality, stress, muscle activity, among others. Public databases offer records with medical labels and signals of different natures, but they do not include instructions directly applicable to new hardware. This gap is precisely where large language models can add value. A controlled analyst workflow synthesizes the documentation of a corpus, proposes candidate rules and organizes them so that an engineering team can evaluate them before a clinical validation.
In a recent controlled study on 68 open physiological corpora, selected for compatibility with commercial use, a workflow with four independent commercial LLM families was applied. Each family produced candidate rules from the corpus documentation. The initial result was 695 rule markers. After removing duplicates, 649 records remained. A threshold and bounds audit detected 51 inconsistencies that were corrected or sent for curator review. The cross-corpus consolidation produced 436 unique rule shapes. Then, through gates based on two strict invariants, 94 components were identified as ready for immediate construction, spread across four detector-family categories.
The two invariants that were applied are especially relevant in production environments. The first checks native availability of capture channels on the target hardware; it would make no sense to validate a rule that requires signals the device cannot obtain. The second avoids relying on per-patient personalization over several nights, because many monitoring products cannot require preliminary training from each user. These restrictions turn a theoretical set of rules into a viable engineering catalogue.
These numbers show something relevant: AI does not replace human judgment, but it can amplify it and make it traceable. The result is an auditable library of candidate rules where each rule has an identifiable origin, a model family that proposed it, confidence bounds and a reason why it was accepted or discarded. That traceability is essential in the healthcare sector, where any decision must be auditable. It is also a good example of how to build custom knowledge-management software: it is not limited to applying a model, but builds a governance infrastructure on top of the results. At Q2BSTUDIO we apply this kind of approach in custom software projects, where data quality and traceability are as important as algorithm performance.
Another key aspect is scalability. Processing 68 databases, running several model families and keeping an updated rule repository requires a robust infrastructure. AWS/Azure cloud platforms make it possible to orchestrate these pipelines, store document versions, execute prompts in a controlled way and audit each step. At the same time, physiological data are extremely sensitive, so cybersecurity must be present from the design stage: encryption, access control, identity management and event logging. It is not about adding security at the end, but integrating it into the discovery flow itself.
Furthermore, artificial intelligence does not act alone. Behind a rule discovery system there are AI agents that normalize texts, extract variables, compare definitions and propose thresholds. There are also visualization tools with BI/Power BI so that clinical and technical teams can see which rules exist, which have passed the audits, which corpora support them and which gaps remain open. This reporting layer is essential for making evidence-based decisions and for planning the next development iterations.
The usefulness of this approach goes beyond research. A company developing a telemedicine, occupational health or corporate wellness product needs to identify which data are relevant to its device, which rules it should validate in a prospective study on its hardware, and how to document that evidence before regulatory bodies. The pipeline described does not produce a validated clinical detector; it produces an organized starting point. That distinction is very important to avoid false expectations and to plan trials with realistic criteria.
In an engineering project, this methodology fits well with continuous integration best practices. Candidate rules are updated whenever a new corpus appears or documentation changes. Thresholds are reviewed automatically. Conflicts are sent to curators. Tests are executed to verify that the code implementing a rule is correct. All of this is part of what we at Q2BSTUDIO understand as responsibly applied artificial intelligence: combining powerful models with human and technical verification processes.
Q2BSTUDIO offers custom software development, AI integration, process automation, AWS/Azure cloud consulting, cybersecurity and BI/Power BI solutions. Our accumulated experience in clinical data systems allows us to bring this kind of auditable discovery to production environments. It is not about building an isolated model, but about designing a software architecture that makes it possible to learn from data, document every decision and deliver measurable value to the end user.
In short, auditable rule discovery with LLMs in physiological databases opens a practical door to accelerating innovation in digital health. The combination of open data, language models, AI agents, automation and expert supervision makes it possible to transform heterogeneous information into an engineering asset. Organizations that adopt these methodologies with a rigorous vision will be better prepared to build robust detectors, overcome regulatory barriers and offer products that improve people's quality of life.
